Cargando…
Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256529/ https://www.ncbi.nlm.nih.gov/pubmed/32474119 http://dx.doi.org/10.1053/j.gastro.2020.05.063 |
| _version_ | 1783539929765117952 |
|---|---|
| author | Lees, Charlie W. Regueiro, Miguel Mahadevan, Uma |
| author_facet | Lees, Charlie W. Regueiro, Miguel Mahadevan, Uma |
| author_sort | Lees, Charlie W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7256529 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72565292020-05-29 Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease Lees, Charlie W. Regueiro, Miguel Mahadevan, Uma Gastroenterology Commentary by the AGA Institute 2020-09 2020-05-29 /pmc/articles/PMC7256529/ /pubmed/32474119 http://dx.doi.org/10.1053/j.gastro.2020.05.063 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Lees, Charlie W. Regueiro, Miguel Mahadevan, Uma Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title | Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title_full | Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title_fullStr | Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title_full_unstemmed | Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title_short | Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease |
| title_sort | innovation in inflammatory bowel disease care during the covid-19 pandemic: results of a global telemedicine survey by the international organization for the study of inflammatory bowel disease |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256529/ https://www.ncbi.nlm.nih.gov/pubmed/32474119 http://dx.doi.org/10.1053/j.gastro.2020.05.063 |
| work_keys_str_mv | AT leescharliew innovationininflammatoryboweldiseasecareduringthecovid19pandemicresultsofaglobaltelemedicinesurveybytheinternationalorganizationforthestudyofinflammatoryboweldisease AT regueiromiguel innovationininflammatoryboweldiseasecareduringthecovid19pandemicresultsofaglobaltelemedicinesurveybytheinternationalorganizationforthestudyofinflammatoryboweldisease AT mahadevanuma innovationininflammatoryboweldiseasecareduringthecovid19pandemicresultsofaglobaltelemedicinesurveybytheinternationalorganizationforthestudyofinflammatoryboweldisease AT innovationininflammatoryboweldiseasecareduringthecovid19pandemicresultsofaglobaltelemedicinesurveybytheinternationalorganizationforthestudyofinflammatoryboweldisease |